TPG Growth Invests in MedQuest

Vedanta Biosciences, Inc., a leading clinical-stage microbiome company developing a new category of oral therapies using defined bacterial consortia manufactured from clonal cell banks, today announced the closing of the Series D financing and provided a pipeline update.

Cardiology is the largest pocket of health care spend and the field is in desperate need of innovation.